| cpd01442 | 560071-15-0 | unnatural heptapeptide | GGRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI |
cpd01443 | 560071-14-9 | unnatural heptapeptide | XRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01444 | 560071-13-8 | unnatural heptapeptide | GRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01445 | 560071-12-7 | unnatural heptapeptide | XRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01446 | 560071-11-6 | unnatural heptapeptide | XRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01447 | 560071-09-2 | unnatural heptapeptide | GGRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01448 | 560071-08-1 | unnatural heptapeptide | XRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01449 | 560071-07-0 | unnatural heptapeptide | GRXXXXXR | 9-Acridinecarboxylic acid | Synthesis | amide | Chaltin, Patrick;et.al (2003)
DOI | cpd01450 | 566181-76-8 | | GSXYSCFWKTCT | Combretastatin A4 | Anticancer therapy and tumor imaging, radioisotope internalization | carbamate | Fuselier, Joseph A.et.al (2003)
DOI | cpd01451 | 566181-74-6 | | GSXYSCFWKTCT | Camptothecin | Anticancer therapy and tumor imaging, radioisotope internalization | carbamate | Fuselier, Joseph A.et.al (2003)
DOI | cpd01452 | 566181-71-3 | | GSXYSCFWKTCT | Camptothecin | Anticancer therapy and tumor imaging, radioisotope internalization | carbamate | Fuselier, Joseph A.et.al (2003)
DOI | cpd01453 | 566181-69-9 | | GSXYSCFWKTCT | Camptothecin | Anticancer therapy and tumor imaging, radioisotope internalization | carbamate | Fuselier, Joseph A.et.al (2003)
DOI | cpd01454 | 566181-66-6 | | GSXYSCFWKTCT | Camptothecin | Anticancer therapy and tumor imaging, radioisotope internalization | carbamate | Fuselier, Joseph A.et.al (2003)
DOI | cpd01455 | 566181-64-4 | | GSXYSCFWKTCT | Camptothecin | Anticancer therapy and tumor imaging, radioisotope internalization | carbamate | Fuselier, Joseph A.et.al (2003)
DOI | cpd01456 | 479622-90-7 | tetrapeptide | CVAM | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01457 | 479622-89-4 | SV40 nuclear transport signal peptide analog | CGYGPKKKRKVGG | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01458 | 479622-88-3 | tetrapeptide | CVAM | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01459 | 479622-87-2 | SV40 nuclear transport signal peptide analog | CGYGPKKKRKVGG | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01460 | 479622-86-1 | tetrapeptide | CVAM | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01461 | 479622-85-0 | SV40 nuclear transport signal peptide analog | CGYGPKKKRKVGG | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01462 | 479622-84-9 | tetrapeptide | CVAM | Protoporphyrin IX | Synthesis | sulfide | Razzaque, M.et.al (2002)
DOI | cpd01463 | 477284-86-9 | | AGYAG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01464 | 477284-85-8 | | AGKAG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01465 | 477284-84-7 | | AGAAG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01466 | 477284-83-6 | | GAKYKG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01467 | 477284-82-5 | | ARYRG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01468 | 477284-81-4 | | AKYKG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01469 | 477284-80-3 | | AKYKG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01470 | 477284-79-0 | | AKSKG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI | cpd01471 | 477284-78-9 | | AKKKG | Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, (OC-6-21)- | Synthesis | amide | Copeland, Kimberly D.et.al (2002)
DOI |